SLC transporters as therapeutic targets: emerging opportunities
The DOI matches its Crossref record; 213 of the 213 references it cites were found in a registry or an index.
Abstract
Solute carrier (SLC) transporters - a family of more than 300 membrane-bound proteins that facilitate the transport of a wide array of substrates across biological membranes - have important roles in physiological processes ranging from the cellular uptake of nutrients to the absorption of drugs and other xenobiotics. Several classes of marketed drugs target well-known SLC transporters, such as neurotransmitter transporters, and human genetic studies have provided powerful insight into the roles of more-recently characterized SLC transporters in both rare and common diseases, indicating a wealth of new therapeutic opportunities. This Review summarizes knowledge on the roles of SLC transporters in human disease, describes strategies to target such transporters, and highlights current and investigational drugs that modulate SLC transporters, as well as promising drug targets.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Representative ABC transporters are multi-drug resistance protein 1 (MDR1; P-gp; ABCB1), breast cancer resistance protein (BCRP; ABCG2) and multi-drug-resistance-associated protein 1 (MRP1, ABCC1), while solute carrier (SLC) transporters include organic anion transporters, organic cation transporters and organic anion transport polypeptides [115].”
From Drug Resistance in Colorectal Cancer: From Mechanism to Clinic (2022) · cites this paper as [115]
Citations
Cites
Items 201–213 of 213
Zheng, X., Pan, Y., Acharya, C., Swaan, P. W., & Polli, J. E. (2010) · Bioconjugate Chemistry · doi:10.1021/bc100273w · Cited by 17
In vitro methods in drug transporter interaction assessment
Jani, M., & Krajcsi, P. (2014) · Drug Discovery Today Technologies · doi:10.1016/j.ddtec.2014.03.011 · Cited by 16
Sharma, H., Santra, S., Debnath, J., Antonio, T., Reith, M., & Dutta, A. K. (2013) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2013.11.017 · Cited by 15
Tetrapeptide inhibitors of the glutamate vesicular transporter (VGLUT)
Patel, S. A., Nagy, J. O., Bolstad, E. S. D., Gerdes, J. M., & Thompson, C. M. (2007) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2007.07.006 · Cited by 15
Amino Acid Transporter-Targeted Radiotracers for Molecular Imaging in Oncology
Kong, F., & Yang, D. J. (2012) · Current Medicinal Chemistry · doi:10.2174/092986712801215946 · Cited by 15
Increased [3H]Tiagabine Binding to GAT-1 in the Cingulate Cortex in Schizophrenia
Sundman-Eriksson, I., Blennow, K., Davidsson, P., et al. (2002) · Neuropsychobiology · doi:10.1159/000048666 · Cited by 14
Lapuerta, P., Rosenstock, J., Zambrowicz, B., Powell, D. R., Ogbaa, I., Freiman, J. P., Cefalu, W. T., Banks, P. L., Frazier, K., Kelly, M., et al. (2013) · Clinical Cardiology · doi:10.1002/clc.22125 · Cited by 13
In Vitro 2-Deoxy-2-[ 18 F]Fluoro-D-Glucose Uptake: Practical Considerations
Mertens, K., Mees, G., Lambert, B., de Wiele, C. V., & Goethals, I. (2012) · Cancer Biotherapy and Radiopharmaceuticals · doi:10.1089/cbr.2011.1125 · Cited by 12
Hereditary conjugated hyperbilirubinaemia: 37years later
Dhumeaux, D., & Erlinger, S. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.08.025 · Cited by 10
Santra, S., Gogoi, S., Gopishetty, B., Antonio, T., Zhen, J., Reith, M. E. A., & Dutta, A. K. (2012) · ChemMedChem · doi:10.1002/cmdc.201200352 · Cited by 10
A novel target for diuretic therapy.
Soleimani, M. (2012) · Iranian Journal of Kidney Diseases · Cited by 7
Snapshot of Antidepressants at Work: The Structure of Neurotransmitter Transporter Proteins
Cuboni, S., & Hausch, F. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201310567 · Cited by 7
Alasti, F., Camp, G. V., & Smith, R. J. (2014) · Cited by 4
Research works printed but not linked: 1
- Feld, L. G. Renal glycosuria. Dayton Children's [online], (2003).
Cited by
A blood–brain barrier overview on structure, function, impairment, and biomarkers of integrity
Kadry, H., Noorani, B., & Cucullo, L. (2020) · Fluids and Barriers of the CNS · doi:10.1186/s12987-020-00230-3 · Cited by 1,853
“This includes more than 300 transporter genes encoding membrane-bound proteins that facilitate the transport of a wide array of substrates across biological membranes [130].”
BackgroundEstablishment and Dysfunction of the Blood-Brain Barrier
Zhao, Z., Nelson, A. R., Betsholtz, C., & Zlokovic, B. V. (2015) · Cell · doi:10.1016/j.cell.2015.10.067 · Cited by 1,670
A Call for Systematic Research on Solute Carriers
César-Razquin, A., Snijder, B., Frappier-Brinton, T., Isserlin, R., Gyimesi, G., Bai, X., Reithmeier, R. A., Hepworth, D., Hediger, M. A., Edwards, A. M., et al. (2015) · Cell · doi:10.1016/j.cell.2015.07.022 · Cited by 580
Understanding Cell Penetration of Cyclic Peptides
Dougherty, P. G., Sahni, A., & Pei, D. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.9b00008 · Cited by 570
The Deubiquitylase OTUB1 Mediates Ferroptosis via Stabilization of SLC7A11
Liu, T., Jiang, L., Tavana, O., & Gu, W. (2019) · Cancer Research · doi:10.1158/0008-5472.can-18-3037 · Cited by 490
Metadata
- Authors
- Lin, L., Yee, S. W., Kim, R. B., & Giacomini, K. M.
- Affiliations
- University of California, San Francisco (US)
- Western University (CA)
- Corresponding author
- Giacomini, Kathleen M.
- Venue
- Nature Reviews Drug Discovery
- Published
- 2015-06-26
- Volume
- 14
- Issue
- 8
- Pages
- 543-560
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W2191975304
- Cited by
- 835
- References
- 213
- Citations by year
- 2026: 67 · 2025: 86 · 2024: 97 · 2023: 102 · 2022: 104 · 2021: 100 · 2020: 72 · 2019: 66 · 2018: 52 · 2017: 47 · 2016: 36 · 2015: 5
- FWCI
- 5.02
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature Reviews Drug Discovery (publishedVersion)
- PubMed (publishedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Scholarship@Western (Western University) (submittedVersion)
- Funders
- Canadian Institutes of Health Research (117588_1, MOP-89753)
- National Institute of General Medical Sciences (GM61390, U19GM061390, T32GM007175, U01GM061390)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK103729, DK103729, P30DK026743)
- Topics
- Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Amino Acid Enzymes and Metabolism
- Keywords
- solute carrier transporters, therapeutic target, transporter modulation, neurotransmitter transporters, monogenic disorders, rare diseases, drug absorption, xenobiotic transport, therapeutic drugs, drug repurposing
- MeSH terms
- Animals, Biological Transport, Humans, Drug Design, Xenobiotics, Drugs, Investigational, Membrane Transport Proteins, Molecular Targeted Therapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.